Redmile Group, LLC Tandem Diabetes Care Inc Transaction History

Redmile Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $4.46 Million - $10.3 Million	-83,758 Reduced 30.88%	187,460 $11.1 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $27.6 Million - $40.7 Million	271,218 New	271,218 $31.5 Million
Q2 2020 Aug 14, 2020	SELL	$60.05 - $98.92 $52.9 Million - $87.2 Million	-881,266 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$47.37 - $90.04 $13.8 Million - $26.2 Million	-290,966 Reduced 24.82%	881,266 $56.7 Million
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $628,581 - $842,248	11,831 Added 1.02%	1,172,232 $69.9 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $321,586 - $412,752	-5,631 Reduced 0.48%	1,160,401 $68.4 Million
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $16.9 Million - $22.2 Million	310,100 Added 36.23%	1,166,032 $75.2 Million
Q1 2019 May 15, 2019	SELL	$32.25 - $73.56 $5.93 Million - $13.5 Million	-183,818 Reduced 17.68%	855,932 $54.4 Million
Q4 2018 Feb 14, 2019	SELL	$28.45 - $40.65 $851,224 - $1.22 Million	-29,920 Reduced 2.8%	1,039,750 $39.5 Million
Q3 2018 Nov 14, 2018	BUY	$21.39 - $51.17 $22.9 Million - $54.7 Million	1,069,670 New	1,069,670 $45.8 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.